{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:19:17Z","timestamp":1790191157397,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001454","name":"American Epilepsy Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001454","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.nbd.2020.105147","type":"journal-article","created":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T02:27:22Z","timestamp":1603592842000},"page":"105147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Nanoparticle encapsulated oxytocin increases resistance to induced seizures and restores social behavior in Scn1a-derived epilepsy"],"prefix":"10.1016","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0602-6351","authenticated-orcid":false,"given":"Jennifer C.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquelyn T.","family":"Thelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Heaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rokon U.","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin S.","family":"Murnane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Escayg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2020.105147_bb0005","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.neuropharm.2014.05.041","article-title":"Neonatal melanocortin receptor agonist treatment reduces play fighting and promotes adult attachment in prairie voles in a sex-dependent manner","volume":"85","author":"Barrett","year":"2014","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.nbd.2020.105147_bb0010","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","article-title":"Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy","volume":"47","author":"Barton","year":"2001","journal-title":"Epilepsy Res."},{"issue":"3","key":"10.1016\/j.nbd.2020.105147_bb0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00008877-199504000-00001","article-title":"Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures","volume":"6","author":"Broqua","year":"1995","journal-title":"Behav. Pharmacol."},{"issue":"1","key":"10.1016\/j.nbd.2020.105147_bb0020","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0163-7258(83)90056-6","article-title":"Vasopressin and oxytocin--their role in neurotransmission","volume":"22","author":"Buijs","year":"1983","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2020.105147_bb0025","doi-asserted-by":"crossref","first-page":"253210","DOI":"10.1155\/2013\/253210","article-title":"The role of neurotransmitters in protection against amyloid- beta toxicity by KiSS-1 overexpression in SH-SY5Y neurons","volume":"2013","author":"Chilumuri","year":"2013","journal-title":"ISRN Neurosci."},{"issue":"6","key":"10.1016\/j.nbd.2020.105147_bb0030","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/320609","article-title":"De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy","volume":"68","author":"Claes","year":"2001","journal-title":"Am. J. Hum. Genet."},{"issue":"10","key":"10.1016\/j.nbd.2020.105147_bb0035","doi-asserted-by":"crossref","first-page":"E904","DOI":"10.1002\/humu.21083","article-title":"The SCN1A variant database: a novel research and diagnostic tool","volume":"30","author":"Claes","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nbd.2020.105147_bb0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2013.01.039","article-title":"Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-beta (Abeta(1-40)) administration in mice","volume":"244","author":"dos Santos","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2020.105147_bb0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.expneurol.2017.03.026","article-title":"Early-life febrile seizures worsen adult phenotypes in Scn1a mutants","volume":"293","author":"Dutton","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2020.105147_bb0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.peptides.2012.12.003","article-title":"Oxytocin inhibits pentylentetrazol-induced seizures in the rat","volume":"40","author":"Erbas","year":"2013","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.nbd.2020.105147_bb0055","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.pharep.2017.03.003","article-title":"Intra-hippocampal microinjection of oxytocin produced antiepileptic effect on the pentylenetetrazol-induced epilepsy in rats","volume":"69","author":"Erfanparast","year":"2017","journal-title":"Pharmacol. Rep."},{"issue":"9","key":"10.1016\/j.nbd.2020.105147_bb0060","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/j.1528-1167.2010.02640.x","article-title":"Sodium channel SCN1A and epilepsy: mutations and mechanisms","volume":"51","author":"Escayg","year":"2010","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.nbd.2020.105147_bb0065","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/74159","article-title":"Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2","volume":"24","author":"Escayg","year":"2000","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.nbd.2020.105147_bb0070","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1086\/319524","article-title":"A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus--and prevalence of variants in patients with epilepsy","volume":"68","author":"Escayg","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2020.105147_bb0075","first-page":"363","article-title":"Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model","volume":"6","author":"Eskandari","year":"2011","journal-title":"Int. J. Nanomedicine"},{"issue":"3","key":"10.1016\/j.nbd.2020.105147_bb0080","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/77040","article-title":"Social amnesia in mice lacking the oxytocin gene","volume":"25","author":"Ferguson","year":"2000","journal-title":"Nat. Genet."},{"issue":"21","key":"10.1016\/j.nbd.2020.105147_bb0085","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/sj.gt.3303013","article-title":"Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo","volume":"14","author":"Foti","year":"2007","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.nbd.2020.105147_bb0090","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.neuroscience.2005.11.008","article-title":"Melanotan-II: investigation of the inducer and facilitator effects on penile erection in anaesthetized rat","volume":"138","author":"Giuliano","year":"2006","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.nbd.2020.105147_bb0095","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.biopsych.2009.09.020","article-title":"Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders","volume":"67","author":"Guastella","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.nbd.2020.105147_bb0100","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/nm901","article-title":"Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion","volume":"9","author":"Haberman","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2020.105147_bb0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3389\/fnbeh.2013.00195","article-title":"Oxytocin receptor ligand binding in embryonic tissue and postnatal brain development of the C57BL\/6J mouse","volume":"7","author":"Hammock","year":"2013","journal-title":"Front. Behav. Neurosci."},{"issue":"7416","key":"10.1016\/j.nbd.2020.105147_bb0110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature11356","article-title":"Autistic-like behaviour in Scn1a+\/\u2010 mice and rescue by enhanced GABA-mediated neurotransmission","volume":"489","author":"Han","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2020.105147_bb0115","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.yhbeh.2017.09.013","article-title":"Oxytocin attenuates deficits in social interaction but not recognition memory in a prenatal valproic acid-induced mouse model of autism","volume":"96","author":"Hara","year":"2017","journal-title":"Horm Behav"},{"issue":"9","key":"10.1016\/j.nbd.2020.105147_bb0120","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/hipo.22595","article-title":"Oxytocin depolarizes fast-spiking hilar interneurons and induces GABA release onto mossy cells of the rat dentate gyrus","volume":"26","author":"Harden","year":"2016","journal-title":"Hippocampus"},{"issue":"8","key":"10.1016\/j.nbd.2020.105147_bb0125","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00125-005-1838-8","article-title":"Intracerebroventricular administration of melanotan II increases insulin sensitivity of glucose disposal in mice","volume":"48","author":"Heijboer","year":"2005","journal-title":"Diabetologia"},{"issue":"2\u20133","key":"10.1016\/j.nbd.2020.105147_bb0130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0014-2999(88)90384-6","article-title":"Neuropeptide Y (NPY)-induced suppression of activity in the rat: evidence for NPY receptor heterogeneity and for interaction with alpha-adrenoceptors","volume":"157","author":"Heilig","year":"1988","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.nbd.2020.105147_bb0135","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/BF00441953","article-title":"Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models","volume":"98","author":"Heilig","year":"1989","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.nbd.2020.105147_bb0140","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/npp.1993.35","article-title":"Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects","volume":"8","author":"Heilig","year":"1993","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.nbd.2020.105147_bb0145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.npp.1300021","article-title":"Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger\u2019s disorders","volume":"28","author":"Hollander","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.nbd.2020.105147_bb0150","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.biopsych.2006.05.030","article-title":"Oxytocin increases retention of social cognition in autism","volume":"61","author":"Hollander","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.nbd.2020.105147_bb0155","article-title":"Mutations in the Scn8a DIIS4 voltage sensor reveal new distinctions among hypomorphic and null Nav 1.6 sodium channels","author":"Inglis","year":"2019","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.nbd.2020.105147_bb0160","doi-asserted-by":"crossref","first-page":"35659","DOI":"10.1038\/srep35659","article-title":"Oxytocin modulates GABAAR subunits to confer neuroprotection in stroke in vitro","volume":"6","author":"Kaneko","year":"2016","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.nbd.2020.105147_bb0165","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1161\/STROKEAHA.111.628008","article-title":"Oxytocin mediates social neuroprotection after cerebral ischemia","volume":"42","author":"Karelina","year":"2011","journal-title":"Stroke"},{"issue":"1\u20132","key":"10.1016\/j.nbd.2020.105147_bb0170","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0006-8993(98)00076-6","article-title":"Anxiolytic-like effect of neuropeptide Y (NPY) and NPY13-36 microinjected into vicinity of locus coeruleus in rats","volume":"788","author":"Kask","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2020.105147_bb0175","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.cej.2018.03.176","article-title":"Bioengineered PLGA-chitosan nanoparticles for brain targeted intranasal delivery of antiepileptic TRH analogues","volume":"346","author":"Kaur","year":"2018","journal-title":"Chem. Eng. J."},{"issue":"3","key":"10.1016\/j.nbd.2020.105147_bb0180","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0196-9781(01)00345-X","article-title":"Repeated inhibitory effects of NPY on hippocampal CA3 seizures and wet dog shakes","volume":"22","author":"Klemp","year":"2001","journal-title":"Peptides"},{"issue":"24","key":"10.1016\/j.nbd.2020.105147_bb0185","doi-asserted-by":"crossref","first-page":"14006","DOI":"10.1073\/pnas.231496298","article-title":"Suppressed kindling epileptogenesis in mice with ectopic overexpression of galanin","volume":"98","author":"Kokaia","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nbd.2020.105147_bb0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nbd.2017.02.006","article-title":"SCN3A deficiency associated with increased seizure susceptibility","volume":"102","author":"Lamar","year":"2017","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.nbd.2020.105147_bb0195","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.biopsych.2015.05.003","article-title":"Intranasal oxytocin: myths and delusions","volume":"79","author":"Leng","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.nbd.2020.105147_bb0200","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.coph.2008.07.001","article-title":"Oxytocin and the maternal brain","volume":"8","author":"Leng","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"issue":"4","key":"10.1016\/j.nbd.2020.105147_bb0205","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.yhbeh.2006.06.028","article-title":"Neuropeptidergic regulation of affiliative behavior and social bonding in animals","volume":"50","author":"Lim","year":"2006","journal-title":"Horm. Behav."},{"key":"10.1016\/j.nbd.2020.105147_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2018.10.003","article-title":"Oxytocin receptor signaling in the hippocampus: role in regulating neuronal excitability, network oscillatory activity, synaptic plasticity and social memory","volume":"171","author":"Lin","year":"2018","journal-title":"Prog. Neurobiol."},{"issue":"7","key":"10.1016\/j.nbd.2020.105147_bb0215","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1046\/j.1460-9568.2003.02926.x","article-title":"Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development","volume":"18","author":"Lin","year":"2003","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2020.105147_bb0220","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41467-017-00675-5","article-title":"Oxytocin stimulates hippocampal neurogenesis via oxytocin receptor expressed in CA3 pyramidal neurons","volume":"8","author":"Lin","year":"2017","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.nbd.2020.105147_bb0225","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1523\/JNEUROSCI.1896-17.2017","article-title":"Conditional deletion of hippocampal CA2\/CA3a oxytocin receptors impairs the persistence of long-term social recognition memory in mice","volume":"38","author":"Lin","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2020.105147_bb0230","first-page":"72","article-title":"Intranasal administration of carbamazepine-loaded carboxymethyl chitosan nanoparticles for drug delivery to the brain","volume":"13","author":"Liu","year":"2018","journal-title":"Asian J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.nbd.2020.105147_bb0235","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.braindev.2008.07.011","article-title":"A catalog of SCN1A variants","volume":"31","author":"Lossin","year":"2009","journal-title":"Brain Dev."},{"key":"10.1016\/j.nbd.2020.105147_bb0240","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainres.2011.11.059","article-title":"Proconvulsive effects of oxytocin in the generalized pentylenetetrazol mouse model are mediated by vasopressin 1a receptors","volume":"1436","author":"Loyens","year":"2012","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.nbd.2020.105147_bb0245","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2826.2012.02303.x","article-title":"Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics","volume":"24","author":"Manning","year":"2012","journal-title":"J Neuroendocrinol"},{"issue":"13","key":"10.1016\/j.nbd.2020.105147_bb0250","doi-asserted-by":"crossref","first-page":"9823","DOI":"10.1074\/jbc.M109.078568","article-title":"Altered function of the SCN1A voltage-gated sodium channel leads to gamma-aminobutyric acid-ergic (GABAergic) interneuron abnormalities","volume":"285","author":"Martin","year":"2010","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.nbd.2020.105147_bb0255","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0304-3940(02)00847-9","article-title":"Anticonvulsant effects of four neuropeptides in the rat hippocampus during self-sustaining status epilepticus","volume":"331","author":"Mazarati","year":"2002","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.nbd.2020.105147_bb0260","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0006-8993(92)91179-I","article-title":"Anticonvulsive effects of galanin administered into the central nervous system upon the picrotoxin-kindled seizure syndrome in rats","volume":"589","author":"Mazarati","year":"1992","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.nbd.2020.105147_bb0265","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/gbb.12099","article-title":"Mapping genetic modifiers of survival in a mouse model of Dravet syndrome","volume":"13","author":"Miller","year":"2014","journal-title":"Genes Brain Behav."},{"issue":"1","key":"10.1016\/j.nbd.2020.105147_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210389","article-title":"Melanotan-II reverses autistic features in a maternal immune activation mouse model of autism","volume":"14","author":"Minakova","year":"2019","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.nbd.2020.105147_bb0275","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1523\/JNEUROSCI.2409-15.2016","article-title":"A Distributed Network for Social Cognition Enriched for Oxytocin Receptors","volume":"36","author":"Mitre","year":"2016","journal-title":"J Neurosci"},{"issue":"8","key":"10.1016\/j.nbd.2020.105147_bb0280","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1038\/npp.2015.35","article-title":"Melanocortin receptor agonists facilitate oxytocin-dependent partner preference formation in the prairie vole","volume":"40","author":"Modi","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.nbd.2020.105147_bb0285","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1365-2826.2011.02141.x","article-title":"Recent findings on neuroprotection against excitotoxicity in the hippocampus of female rats","volume":"23","author":"Morales","year":"2011","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.nbd.2020.105147_bb0290","first-page":"301","article-title":"Identification of agonist binding sites of vasopressin and oxytocin receptors","volume":"395","author":"Mouillac","year":"1995","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.nbd.2020.105147_bb0295","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0006-8993(84)90921-1","article-title":"Contrasting effects of neurohypophysial peptides on pyramidal and non-pyramidal neurones in the rat hippocampus","volume":"308","author":"Muhlethaler","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2020.105147_bb0300","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejpb.2018.11.002","article-title":"Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents","volume":"133","author":"Musumeci","year":"2018","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nbd.2020.105147_bb0305","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yhbeh.2018.12.011","article-title":"Nanoparticle encapsulation increases the brain penetrance and duration of action of intranasal oxytocin","volume":"108","author":"Oppong-Damoah","year":"2019","journal-title":"Horm. Behav."},{"issue":"7463","key":"10.1016\/j.nbd.2020.105147_bb0310","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nature12330","article-title":"Oxytocin enhances hippocampal spike transmission by modulating fast-spiking interneurons","volume":"500","author":"Owen","year":"2013","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.nbd.2020.105147_bb0315","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/epi.12060","article-title":"Altered sleep regulation in a mouse model of SCN1A-derived genetic epilepsy with febrile seizures plus (GEFS+)","volume":"54","author":"Papale","year":"2013","journal-title":"Epilepsia"},{"issue":"271","key":"10.1016\/j.nbd.2020.105147_bb0320","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010257","article-title":"Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism","volume":"7","author":"Penagarikano","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.nbd.2020.105147_bb0325","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/(SICI)1098-2396(199608)23:4<312::AID-SYN9>3.0.CO;2-A","article-title":"Activation of oxytocin-containing neurons of the paraventricular nucleus (PVN) following generalized seizures","volume":"23","author":"Piekut","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.nbd.2020.105147_bb0330","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-013-3034-8","article-title":"Effects of an epilepsy-causing mutation in the SCN1A sodium channel gene on cocaine-induced seizure susceptibility in mice","author":"Purcell","year":"2013","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.nbd.2020.105147_bb0335","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.pbb.2006.09.023","article-title":"The melanocortin agonist, melanotan II, enhances proceptive sexual behaviors in the female rat","volume":"85","author":"Rossler","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"9","key":"10.1016\/j.nbd.2020.105147_bb0340","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.biopsych.2010.12.022","article-title":"Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism","volume":"69","author":"Sala","year":"2011","journal-title":"Biol Psychiatry"},{"issue":"24","key":"10.1016\/j.nbd.2020.105147_bb0345","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.1523\/JNEUROSCI.1594-10.2010","article-title":"Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse","volume":"30","author":"Schorscher-Petcu","year":"2010","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.nbd.2020.105147_bb0350","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI116554","article-title":"Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors","volume":"92","author":"Serradeil-Le Gal","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.nbd.2020.105147_bb0355","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/epi.16388","article-title":"Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice","volume":"60","author":"Shapiro","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2020.105147_bb0360","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.psyneuen.2014.08.005","article-title":"Oxytocin induces social communication by activating arginine-vasopressin V1a receptors and not oxytocin receptors","volume":"50","author":"Song","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.nbd.2020.105147_bb0365","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuron.2012.09.025","article-title":"Neuromodulation by oxytocin and vasopressin","volume":"76","author":"Stoop","year":"2012","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.nbd.2020.105147_bb0370","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.brainres.2004.11.022","article-title":"Neuropeptide Y suppresses absence seizures in a genetic rat model","volume":"1033","author":"Stroud","year":"2005","journal-title":"Brain Res."},{"issue":"1\u20133","key":"10.1016\/j.nbd.2020.105147_bb0375","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0014-2999(02)02945-X","article-title":"The potent melanocortin receptor agonist melanotan-II promotes peripheral nerve regeneration and has neuroprotective properties in the rat","volume":"462","author":"Ter Laak","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.nbd.2020.105147_bb0380","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.neuron.2018.09.008","article-title":"Oxytocin transforms firing mode of CA2 hippocampal neurons","volume":"100","author":"Tirko","year":"2018","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.nbd.2020.105147_bb0385","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.npep.2004.05.004","article-title":"Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy?","volume":"38","author":"Vezzani","year":"2004","journal-title":"Neuropeptides"},{"issue":"4","key":"10.1016\/j.nbd.2020.105147_bb0390","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1086\/319516","article-title":"Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus","volume":"68","author":"Wallace","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.nbd.2020.105147_bb0395","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1212\/01.WNL.0000086379.71183.78","article-title":"Sodium channel alpha1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms","volume":"61","author":"Wallace","year":"2003","journal-title":"Neurology"},{"issue":"23","key":"10.1016\/j.nbd.2020.105147_bb0400","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1021\/jm00023a002","article-title":"1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist","volume":"38","author":"Williams","year":"1995","journal-title":"J. Med. Chem."},{"issue":"1\u20132","key":"10.1016\/j.nbd.2020.105147_bb0405","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2014.05.056","article-title":"Albumin nanoparticles for the delivery of gabapentin: preparation, characterization and pharmacodynamic studies","volume":"473","author":"Wilson","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"357","key":"10.1016\/j.nbd.2020.105147_bb0410","article-title":"Huperzine A provides robust and sustained protection against induced seizures in Scn1a mutant mice","volume":"7","author":"Wong","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.nbd.2020.105147_bb0415","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/acn3.50848","article-title":"Donepezil increases resistance to induced seizures in a mouse model of Dravet syndrome","volume":"6","author":"Wong","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"9","key":"10.1016\/j.nbd.2020.105147_bb0420","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/nn1754","article-title":"Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy","volume":"9","author":"Yu","year":"2006","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.nbd.2020.105147_bb0425","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ijpharm.2018.07.043","article-title":"Nanoparticle formulations that allow for sustained delivery and brain targeting of the neuropeptide oxytocin","volume":"548","author":"Zaman","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.nbd.2020.105147_bb0430","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1046\/j.1460-9568.2000.00290.x","article-title":"Oxytocin receptor agonists enhance inhibitory synaptic transmission in the rat hippocampus by activating interneurons in stratum pyramidale","volume":"12","author":"Zaninetti","year":"2000","journal-title":"Eur. J. Neurosci."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120304228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996120304228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:24:47Z","timestamp":1760851487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996120304228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":86,"alternative-id":["S0969996120304228"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2020.105147","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticle encapsulated oxytocin increases resistance to induced seizures and restores social behavior in Scn1a-derived epilepsy","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2020.105147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105147"}}